Suki’s $70 million Series D financing round was led by Hedosophia and included participation from Venrock, March Capital, Flare Capital, Breyer Capital and inHealth Ventures.
The post Suki Secures $70M To Expand AI Offerings appeared first on MedCity News.
Recent Posts
Categories
Related Articles
Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses?
Cost effectiveness analyses (CEA) aim to examine how a new health technologies...
5 Interesting Companies I Saw at HLTH
I met a mix of biotech and healthtech companies at HLTH affecting...
Patty Hayward, TalkDesk
Patty Hayward is GM of Healthcare and Life Sciences at TalkDesk. TalkDesk...
How chatbots are enhancing patient care
Consumers have come to expect options when communicating with the companies they...
Leave a comment